Medindia LOGIN REGISTER
Medindia

Pioglitazone Interaction with other Drugs


Pioglitazone is a thiazolidinedione antidiabetic, prescribed for type 2 diabetes in certain patients.

Pioglitazone Interaction with 405 drugs. Find out more in the list below:

17-alpha-Hydroxyprogesterone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydroxyprogesterone caproate.

Abiraterone


The serum concentration of Pioglitazone can be increased when it is combined with Abiraterone.

Acetaminophen


The metabolism of Acetaminophen can be decreased when combined with Pioglitazone.

Advertisement

Acetohexamide


Pioglitazone may increase the hypoglycemic activities of Acetohexamide.

Acetyl salicylate


The metabolism of Acetylsalicylic acid can be decreased when combined with Pioglitazone.

Almotriptan


The metabolism of Almotriptan can be decreased when combined with Pioglitazone.

Advertisement

Aloxiprin


Aloxiprin may increase the hypoglycemic activities of Pioglitazone.

Aminopyrine


The metabolism of Aminophenazone can be decreased when combined with Pioglitazone.

Aminosalicylic Acid


Aminosalicylic Acid may increase the hypoglycemic activities of Pioglitazone.

Advertisement

Amiodarone


The metabolism of Pioglitazone can be decreased when combined with Amiodarone.

Amitriptyline


The metabolism of Amitriptyline can be decreased when combined with Pioglitazone.

Amodiaquine


The metabolism of Amodiaquine can be decreased when combined with Pioglitazone.

Amphetamine


Amphetamine may increase the hypoglycemic activities of Pioglitazone.

Amprenavir


The metabolism of Amprenavir can be decreased when combined with Pioglitazone.

Anhydrous Tacrolimus


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Tacrolimus.

Antipyrine


The metabolism of Antipyrine can be decreased when combined with Pioglitazone.

Apalutamide


The serum concentration of Pioglitazone can be decreased when it is combined with Apalutamide.

Apixaban


The metabolism of Apixaban can be decreased when combined with Pioglitazone.

Aprepitant


The serum concentration of Pioglitazone can be increased when it is combined with Aprepitant.

Aripiprazole


The serum concentration of Aripiprazole can be decreased when it is combined with Pioglitazone.

Arsenic Trioxide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Arsenic trioxide.

Articaine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Articaine.

Asenapine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Asenapine.

Aspirin


The metabolism of Acetylsalicylic acid can be decreased when combined with Pioglitazone.

Atazanavir


The metabolism of Pioglitazone can be decreased when combined with Atazanavir.

Atomoxetine


The metabolism of Pioglitazone can be decreased when combined with Atomoxetine.

Atorvastatin


The metabolism of Atorvastatin can be decreased when combined with Pioglitazone.

Azelastine


The metabolism of Azelastine can be decreased when combined with Pioglitazone.

Balsalazide


Balsalazide may increase the hypoglycemic activities of Pioglitazone.

Bendroflumethiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Bendroflumethiazide.

Benzyl Alcohol


The metabolism of Benzyl alcohol can be decreased when combined with Pioglitazone.

Betamethasone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Betamethasone.

Boceprevir


The metabolism of Pioglitazone can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Pioglitazone can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Pioglitazone can be decreased when it is combined with Bosentan.

Brexpiprazole


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Brexpiprazole.

Brigatinib


The metabolism of Brigatinib can be decreased when combined with Pioglitazone.

Brompheniramine


The metabolism of Brompheniramine can be decreased when combined with Pioglitazone.

Bumetanide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Bumetanide.

Buprenorphine


The metabolism of Buprenorphine can be decreased when combined with Pioglitazone.

Bupropion


The metabolism of Bupropion can be decreased when combined with Pioglitazone.

Buserelin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Buserelin.

Cabazitaxel


The metabolism of Cabazitaxel can be decreased when combined with Pioglitazone.

Caffeine


The metabolism of Caffeine can be decreased when combined with Pioglitazone.

Capecitabine


The metabolism of Pioglitazone can be decreased when combined with Capecitabine.

Carbamazepine


The metabolism of Pioglitazone can be increased when combined with Carbamazepine.

Carbinoxamine


The metabolism of Carbinoxamine can be decreased when combined with Pioglitazone.

Celecoxib


The metabolism of Pioglitazone can be decreased when combined with Celecoxib.

Ceritinib


The serum concentration of Pioglitazone can be increased when it is combined with Ceritinib.

Cerivastatin


The metabolism of Cerivastatin can be decreased when combined with Pioglitazone.

Chloroquine


The metabolism of Chloroquine can be decreased when combined with Pioglitazone.

Chlorothiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Chlorothiazide.

Chlorpropamide


Pioglitazone may increase the hypoglycemic activities of Chlorpropamide.

Chlorthalidone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Chlorthalidone.

Cholecalciferol


The metabolism of Pioglitazone can be decreased when combined with Cholecalciferol.

Cilostazol


The serum concentration of Cilostazol can be increased when it is combined with Pioglitazone.

Cinoxacin


Cinoxacin may increase the hypoglycemic activities of Pioglitazone.

Cisapride


The metabolism of Cisapride can be decreased when combined with Pioglitazone.

Citalopram


Citalopram may increase the hypoglycemic activities of Pioglitazone.

Clarithromycin


The metabolism of Pioglitazone can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Pioglitazone can be decreased when combined with Clemastine.

Clofezone


The metabolism of Pioglitazone can be decreased when combined with Rabeprazole.

Clotrimazole


The metabolism of Pioglitazone can be decreased when combined with Clotrimazole.

Clozapine


The metabolism of Clozapine can be decreased when combined with Pioglitazone.

Cobicistat


The metabolism of Pioglitazone can be decreased when combined with Cobicistat.

coenzyme Q10


The therapeutic efficacy of Pioglitazone can be increased when used in combination with Ubidecarenone.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Pioglitazone.

Corticotropin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Corticotropin.

Cortisone Acetate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Cortisone acetate.

Crisaborole


The metabolism of Pioglitazone can be decreased when combined with Crisaborole.

Crizotinib


The metabolism of Pioglitazone can be decreased when combined with Crizotinib.

Cyclopenthiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Cyclopenthiazide.

Cyclophosphamide


The metabolism of Cyclophosphamide can be decreased when combined with Pioglitazone.

Cyclophosphamide Anhydrous


The metabolism of Cyclophosphamide can be decreased when combined with Pioglitazone.

Cyclosporine


The metabolism of Pioglitazone can be decreased when combined with Cyclosporine.

Cyproterone Acetate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Cyproterone acetate.

Dabrafenib


The serum concentration of Pioglitazone can be decreased when it is combined with Dabrafenib.

Danazol


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Danazol.

Dapsone


The metabolism of Dapsone can be decreased when combined with Pioglitazone.

Darunavir


The metabolism of Pioglitazone can be decreased when combined with Darunavir.

Dasabuvir


The metabolism of Dasabuvir can be decreased when combined with Pioglitazone.

Dasatinib


The serum concentration of Pioglitazone can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Pioglitazone can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Pioglitazone can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Pioglitazone can be decreased when combined with Delavirdine.

Desogestrel


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Desogestrel.

Desvenlafaxine


Desvenlafaxine may increase the hypoglycemic activities of Pioglitazone.

Dexamethasone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Dexamethasone.

Dextromethorphan


The metabolism of Dextromethorphan can be decreased when combined with Pioglitazone.

Diazepam


The metabolism of Diazepam can be decreased when combined with Pioglitazone.

Diazoxide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Diazoxide.

Diclofenac


The metabolism of Diclofenac can be decreased when combined with Pioglitazone.

Dienogest


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Dienogest.

Diflunisal


Diflunisal may increase the hypoglycemic activities of Pioglitazone.

Dihydroergotamine


The metabolism of Pioglitazone can be decreased when combined with Dihydroergotamine.

Diltiazem


The metabolism of Pioglitazone can be decreased when combined with Diltiazem.

Disopyramide


Pioglitazone may increase the hypoglycemic activities of Disopyramide.

Domperidone


The metabolism of Domperidone can be decreased when combined with Pioglitazone.

Dothiepin


The metabolism of Pioglitazone can be decreased when combined with Dosulepin.

Doxycycline


The metabolism of Pioglitazone can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Pioglitazone can be decreased when combined with Doxycycline.

Dronedarone


The metabolism of Pioglitazone can be decreased when combined with Dronedarone.

Drospirenone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Drospirenone.

Duloxetine


Duloxetine may increase the hypoglycemic activities of Pioglitazone.

Efavirenz


The metabolism of Pioglitazone can be decreased when combined with Efavirenz.

Eltrombopag


The metabolism of Eltrombopag can be decreased when combined with Pioglitazone.

Enasidenib


The metabolism of Enasidenib can be decreased when combined with Pioglitazone.

Enoxacin


Enoxacin may increase the hypoglycemic activities of Pioglitazone.

Enzalutamide


The serum concentration of Pioglitazone can be decreased when it is combined with Enzalutamide.

Epinephrine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Epinephrine.

Erlotinib


The metabolism of Erlotinib can be decreased when combined with Pioglitazone.

Erythromycin


The metabolism of Pioglitazone can be decreased when combined with Erythromycin.

Escitalopram


Escitalopram may increase the hypoglycemic activities of Pioglitazone.

Estradiol


The metabolism of Estradiol can be decreased when combined with Pioglitazone.

Estradiol 3-Benzoate


The metabolism of Estradiol benzoate can be decreased when combined with Pioglitazone.

Estradiol acetate


The metabolism of Estradiol acetate can be decreased when combined with Pioglitazone.

Estradiol Cypionate


The metabolism of Estradiol cypionate can be decreased when combined with Pioglitazone.

Estradiol Valerate


The metabolism of Estradiol valerate can be decreased when combined with Pioglitazone.

Eszopiclone


The metabolism of Eszopiclone can be decreased when combined with Pioglitazone.

Ethacrynate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etacrynic acid.

Ethacrynic Acid


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etacrynic acid.

Ethinyl Estradiol


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Ethinyl Estradiol.

Ethynodiol Diacetate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Ethynodiol diacetate.

Etonogestrel


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etonogestrel.

Etravirine


The metabolism of Pioglitazone can be decreased when combined with Etravirine.

Everolimus


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Everolimus.

Felodipine


The metabolism of Pioglitazone can be decreased when combined with Felodipine.

Fesoterodine


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pioglitazone.

Fleroxacin


Fleroxacin may increase the hypoglycemic activities of Pioglitazone.

Floxuridine


The metabolism of Pioglitazone can be decreased when combined with Floxuridine.

Fluconazole


The metabolism of Pioglitazone can be decreased when combined with Fluconazole.

Fludrocortisone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Fludrocortisone.

Flumequine


Flumequine may increase the hypoglycemic activities of Pioglitazone.

Fluorouracil


The metabolism of Pioglitazone can be decreased when combined with Fluorouracil.

Fluoxetine


Fluoxetine may increase the hypoglycemic activities of Pioglitazone.

Fluoxymesterone


Fluoxymesterone may increase the hypoglycemic activities of Pioglitazone.

Fluvastatin


The metabolism of Pioglitazone can be decreased when combined with Fluvastatin.

Fluvoxamine


The metabolism of Pioglitazone can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Pioglitazone can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Pioglitazone can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The metabolism of Pioglitazone can be increased when combined with Fosphenytoin.

Furazolidone


Furazolidone may increase the hypoglycemic activities of Pioglitazone.

Furosemide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Furosemide.

Fusidate


The serum concentration of Pioglitazone can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Pioglitazone can be increased when it is combined with Fusidic Acid.

Gatifloxacin


Gatifloxacin may increase the hypoglycemic activities of Pioglitazone.

Gatifloxacin Anhydrous


Gatifloxacin may increase the hypoglycemic activities of Pioglitazone.

Gemfibrozil


The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.

Gemifloxacin


Gemifloxacin may increase the hypoglycemic activities of Pioglitazone.

Gemifloxacin Mesylate


Gemifloxacin may increase the hypoglycemic activities of Pioglitazone.

Glibornuride


Pioglitazone may increase the hypoglycemic activities of Glibornuride.

Gliclazide


Pioglitazone may increase the hypoglycemic activities of Gliclazide.

Glimepiride


Pioglitazone may increase the hypoglycemic activities of Glimepiride.

Glipizide


Pioglitazone may increase the hypoglycemic activities of Glipizide.

Gliquidone


Pioglitazone may increase the hypoglycemic activities of Gliquidone.

Glyburide


Pioglitazone may increase the hypoglycemic activities of Glyburide.

Goserelin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Goserelin.

Grepafloxacin


Grepafloxacin may increase the hypoglycemic activities of Pioglitazone.

Halofantrine


The metabolism of Halofantrine can be decreased when combined with Pioglitazone.

Histrelin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Histrelin.

Hydrochlorothiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydrochlorothiazide.

Hydrocortisone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydrocortisone.

Hydroflumethiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydroflumethiazide.

hydroxyprogesterone caproate (USP)


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydroxyprogesterone caproate.

Hypoxis hemerocallidea root extract


The serum concentration of Pioglitazone can be decreased when it is combined with St. John's Wort.

Ibuprofen


The metabolism of Ibuprofen can be decreased when combined with Pioglitazone.

Idelalisib


The metabolism of Pioglitazone can be decreased when combined with Idelalisib.

Ifosfamide


The metabolism of Ifosfamide can be decreased when combined with Pioglitazone.

Iloperidone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Iloperidone.

Imatinib


The metabolism of Pioglitazone can be decreased when combined with Imatinib.

Indapamide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Indapamide.

Indinavir


The metabolism of Pioglitazone can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Pioglitazone can be decreased when combined with Indinavir.

Insulin Detemir


Pioglitazone may increase the hypoglycemic activities of Insulin Detemir.

Insulin Glargine


Pioglitazone may increase the hypoglycemic activities of Insulin Glargine.

insulin human, rDNA origin


The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin Human.

Insulin Lispro


Pioglitazone may increase the hypoglycemic activities of Insulin Lispro.

Insulin, Aspart Protamine, Human


Pioglitazone may increase the hypoglycemic activities of Insulin Aspart.

Insulin, Aspart, Human


Pioglitazone may increase the hypoglycemic activities of Insulin Aspart.

Insulin, Glulisine, Human


Pioglitazone may increase the hypoglycemic activities of Insulin Glulisine.

Insulin, Pork


The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin Pork.

Insulin, Protamine Lispro, Human


Pioglitazone may increase the hypoglycemic activities of Insulin Lispro.

Insulin, Regular, Pork


The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin Pork.

Iproniazid


Iproniazid may increase the hypoglycemic activities of Pioglitazone.

Irbesartan


The metabolism of Pioglitazone can be decreased when combined with Irbesartan.

Isavuconazole


The serum concentration of Pioglitazone can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Pioglitazone can be decreased when combined with Isavuconazonium.

Isocarboxazid


Isocarboxazid may increase the hypoglycemic activities of Pioglitazone.

Isradipine


The metabolism of Pioglitazone can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Pioglitazone can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Pioglitazone can be increased when it is combined with Ivacaftor.

Ixazomib


The metabolism of Ixazomib can be decreased when combined with Pioglitazone.

Ketamine


The metabolism of Ketamine can be decreased when combined with Pioglitazone.

Ketoconazole


The metabolism of Pioglitazone can be decreased when combined with Ketoconazole.

Lanreotide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Lanreotide.

Lansoprazole


The metabolism of Lansoprazole can be decreased when combined with Pioglitazone.

Lapatinib


The metabolism of Lapatinib can be decreased when combined with Pioglitazone.

Leflunomide


The metabolism of Pioglitazone can be decreased when combined with Leflunomide.

Leuprolide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Leuprolide.

Levofloxacin


Levofloxacin may increase the hypoglycemic activities of Pioglitazone.

Levofloxacin Anhydrous


Levofloxacin may increase the hypoglycemic activities of Pioglitazone.

Levomilnacipran


The metabolism of Levomilnacipran can be decreased when combined with Pioglitazone.

Levonorgestrel


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Levonorgestrel.

Lidocaine


The metabolism of Lidocaine can be decreased when combined with Pioglitazone.

Loperamide


The metabolism of Loperamide can be decreased when combined with Pioglitazone.

Lopinavir


The metabolism of Pioglitazone can be decreased when combined with Lopinavir.

Loratadine


The metabolism of Loratadine can be decreased when combined with Pioglitazone.

Losartan


The metabolism of Pioglitazone can be decreased when combined with Losartan.

Lovastatin


The metabolism of Pioglitazone can be decreased when combined with Lovastatin.

Luliconazole


The serum concentration of Pioglitazone can be increased when it is combined with Luliconazole.

Lumacaftor


The serum concentration of Pioglitazone can be increased when it is combined with Lumacaftor.

Lurasidone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Lurasidone.

Manidipine


The metabolism of Pioglitazone can be decreased when combined with Manidipine.

Mecasermin


Pioglitazone may increase the hypoglycemic activities of Mecasermin.

Mecasermin Rinfabate


Pioglitazone may increase the hypoglycemic activities of Mecasermin.

Medrogestone


The serum concentration of Pioglitazone can be decreased when it is combined with Medrogestone.

Medroxyprogesterone Acetate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Medroxyprogesterone acetate.

Mefenamic Acid


The metabolism of Mefenamic acid can be decreased when combined with Pioglitazone.

Megestrol Acetate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Megestrol acetate.

Meloxicam


The metabolism of Meloxicam can be decreased when combined with Pioglitazone.

Mephenytoin


The metabolism of Mephenytoin can be decreased when combined with Pioglitazone.

Mesalamine


Mesalazine may increase the hypoglycemic activities of Pioglitazone.

Mesterolone


Mesterolone may increase the hypoglycemic activities of Pioglitazone.

Mestranol


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Mestranol.

Methadone


The metabolism of Methadone can be decreased when combined with Pioglitazone.

Methotrimeprazine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Methotrimeprazine.

Methyclothiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Methyclothiazide.

Methyl Salicylate


Methyl salicylate may increase the hypoglycemic activities of Pioglitazone.

Methylene blue


Methylene blue may increase the hypoglycemic activities of Pioglitazone.

Methylprednisolone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Methylprednisolone.

Methyltestosterone


Methyltestosterone may increase the hypoglycemic activities of Pioglitazone.

Metolazone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Metolazone.

Metoprolol


The serum concentration of Metoprolol can be increased when it is combined with Pioglitazone.

Midostaurin


The metabolism of Pioglitazone can be decreased when combined with Midostaurin.

Mifepristone


The serum concentration of Pioglitazone can be increased when it is combined with Mifepristone.

Milnacipran


Milnacipran may increase the hypoglycemic activities of Pioglitazone.

Minaprine


Minaprine may increase the hypoglycemic activities of Pioglitazone.

Mirtazapine


The metabolism of Mirtazapine can be decreased when combined with Pioglitazone.

Mitotane


The serum concentration of Pioglitazone can be decreased when it is combined with Mitotane.

Moclobemide


Moclobemide may increase the hypoglycemic activities of Pioglitazone.

Morphine


The metabolism of Morphine can be decreased when combined with Pioglitazone.

Mycophenolate Mofetil


The metabolism of Mycophenolate mofetil can be decreased when combined with Pioglitazone.

Nalidixic Acid


Nalidixic Acid may increase the hypoglycemic activities of Pioglitazone.

Naloxone


The metabolism of Naloxone can be decreased when combined with Pioglitazone.

Nandrolone


Nandrolone may increase the hypoglycemic activities of Pioglitazone.

Nandrolone Decanoate


Nandrolone decanoate may increase the hypoglycemic activities of Pioglitazone.

Naproxen


The metabolism of Naproxen can be decreased when combined with Pioglitazone.

Nateglinide


Pioglitazone may increase the hypoglycemic activities of Nateglinide.

Nefazodone


The metabolism of Pioglitazone can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Pioglitazone can be decreased when combined with Nelfinavir.

Netupitant


The serum concentration of Pioglitazone can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Pioglitazone can be increased when combined with Nevirapine.

Niacin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Niacin.

Nialamide


Nialamide may increase the hypoglycemic activities of Pioglitazone.

Nicardipine


The metabolism of Pioglitazone can be decreased when combined with Nicardipine.

Nicotine


The metabolism of Nicotine can be decreased when combined with Pioglitazone.

Nicotine Polacrilex


The metabolism of Nicotine can be decreased when combined with Pioglitazone.

Nilotinib


The metabolism of Pioglitazone can be decreased when combined with Nilotinib.

Norethindrone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Norethisterone.

Norfloxacin


Norfloxacin may increase the hypoglycemic activities of Pioglitazone.

Norgestimate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Norgestimate.

Octreotide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Octreotide.

Olanzapine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Olanzapine.

Olaparib


The metabolism of Pioglitazone can be decreased when combined with Olaparib.

Olodaterol


The metabolism of Olodaterol can be decreased when combined with Pioglitazone.

Olsalazine


Olsalazine may increase the hypoglycemic activities of Pioglitazone.

Ombitasvir


The metabolism of Ombitasvir can be decreased when combined with Pioglitazone.

Omeprazole


The metabolism of Pioglitazone can be decreased when combined with Omeprazole.

Osimertinib


The serum concentration of Pioglitazone can be increased when it is combined with Osimertinib.

Oxandrolone


Oxandrolone may increase the hypoglycemic activities of Pioglitazone.

Oxymetholone


Oxymetholone may increase the hypoglycemic activities of Pioglitazone.

Paclitaxel


The metabolism of Paclitaxel can be decreased when combined with Pioglitazone.

Palbociclib


The serum concentration of Pioglitazone can be increased when it is combined with Palbociclib.

Paliperidone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Paliperidone.

Paramethadione


The metabolism of Paramethadione can be decreased when combined with Pioglitazone.

Paregoric


The metabolism of Morphine can be decreased when combined with Pioglitazone.

Pargyline


Pargyline may increase the hypoglycemic activities of Pioglitazone.

Paroxetine


Paroxetine may increase the hypoglycemic activities of Pioglitazone.

Pasireotide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Pasireotide.

Pazopanib


The metabolism of Pazopanib can be decreased when combined with Pioglitazone.

Pefloxacin


Pefloxacin may increase the hypoglycemic activities of Pioglitazone.

Pegvisomant


Pegvisomant may increase the hypoglycemic activities of Pioglitazone.

Pentamidine


The metabolism of Pentamidine can be decreased when combined with Pioglitazone.

Pentobarbital


The metabolism of Pioglitazone can be increased when combined with Pentobarbital.

Perphenazine


The metabolism of Perphenazine can be decreased when combined with Pioglitazone.

Phenelzine


Phenelzine may increase the hypoglycemic activities of Pioglitazone.

Phenobarbital


The metabolism of Pioglitazone can be increased when combined with Phenobarbital.

Phenprocoumon


The metabolism of Phenprocoumon can be decreased when combined with Pioglitazone.

Phenytoin


The metabolism of Pioglitazone can be increased when combined with Phenytoin.

Piperazine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Piperazine.

Pipothiazine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Pipotiazine.

Piroxicam


The metabolism of Piroxicam can be decreased when combined with Pioglitazone.

Piroxicam-Beta-Cyclodextrin


The metabolism of Piroxicam can be decreased when combined with Pioglitazone.

Pitavastatin


The metabolism of Pitavastatin can be decreased when combined with Pioglitazone.

Polythiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Polythiazide.

Ponatinib


The metabolism of Ponatinib can be decreased when combined with Pioglitazone.

Posaconazole


The metabolism of Pioglitazone can be decreased when combined with Posaconazole.

Prednisolone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Prednisolone.

Prednisone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Prednisone.

Pregabalin


The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.

Primidone


The metabolism of Pioglitazone can be increased when combined with Primidone.

Procarbazine


Procarbazine may increase the hypoglycemic activities of Pioglitazone.

Progesterone


The metabolism of Progesterone can be decreased when combined with Pioglitazone.

Propofol


The metabolism of Propofol can be decreased when combined with Pioglitazone.

Pyrimethamine


The metabolism of Pioglitazone can be decreased when combined with Pyrimethamine.

Quetiapine


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quetiapine.

Quetiapine fumarate


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quetiapine.

Quinethazone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quinethazone.

Quinidine


The metabolism of Quinidine can be decreased when combined with Pioglitazone.

Quinine


The metabolism of Pioglitazone can be decreased when combined with Quinine.

Rabeprazole


The metabolism of Pioglitazone can be decreased when combined with Rabeprazole.

Ranolazine


The metabolism of Pioglitazone can be decreased when combined with Ranolazine.

Rasagiline


Rasagiline may increase the hypoglycemic activities of Pioglitazone.

Regular Insulin, Human


The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin Human.

Repaglinide


The metabolism of Repaglinide can be decreased when combined with Pioglitazone.

Rifabutin


The metabolism of Pioglitazone can be increased when combined with Rifabutin.

Rifampin


The metabolism of Pioglitazone can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Pioglitazone can be increased when combined with Rifapentine.

Rilpivirine


The serum concentration of Rilpivirine can be decreased when it is combined with Pioglitazone.

Riociguat


The metabolism of Riociguat can be decreased when combined with Pioglitazone.

Risperidone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Risperidone.

Ritonavir


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Ritonavir.

Rofecoxib


The metabolism of Rofecoxib can be decreased when combined with Pioglitazone.

Rosiglitazone


The metabolism of Pioglitazone can be decreased when combined with Rosiglitazone.

Rosoxacin


Rosoxacin may increase the hypoglycemic activities of Pioglitazone.

Rucaparib


The metabolism of Pioglitazone can be decreased when combined with Rucaparib.

Salicylic Acid


Salicylic acid may increase the hypoglycemic activities of Pioglitazone.

Saquinavir


The metabolism of Pioglitazone can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Pioglitazone can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Sarilumab.

Saxagliptin


The serum concentration of Saxagliptin can be decreased when it is combined with Pioglitazone.

Saxagliptin Anhydrous


The serum concentration of Saxagliptin can be decreased when it is combined with Pioglitazone.

Secobarbital


The metabolism of Pioglitazone can be increased when combined with Secobarbital.

Selegiline


The metabolism of Selegiline can be decreased when combined with Pioglitazone.

Selexipag


The metabolism of Selexipag can be decreased when combined with Pioglitazone.

Sertraline


Sertraline may increase the hypoglycemic activities of Pioglitazone.

Sildenafil


The metabolism of Pioglitazone can be decreased when combined with Sildenafil.

Siltuximab


The serum concentration of Pioglitazone can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Pioglitazone can be increased when it is combined with Simeprevir.

Simvastatin


The metabolism of Simvastatin can be decreased when combined with Pioglitazone.

Sirolimus


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Sirolimus.

Sitagliptin


The metabolism of Sitagliptin can be decreased when combined with Pioglitazone.

Sitagliptin Phosphate


The metabolism of Sitagliptin can be decreased when combined with Pioglitazone.

Sorafenib


The metabolism of Pioglitazone can be decreased when combined with Sorafenib.

Sparfloxacin


Sparfloxacin may increase the hypoglycemic activities of Pioglitazone.

ST. JOHN'S WORT EXTRACT


The serum concentration of Pioglitazone can be decreased when it is combined with St. John's Wort.

Stanozolol


Stanozolol may increase the hypoglycemic activities of Pioglitazone.

Sulfadiazine


The metabolism of Pioglitazone can be decreased when combined with Sulfadiazine.

Sulfamethoxazole


The metabolism of Pioglitazone can be decreased when combined with Sulfamethoxazole.

Sulfinpyrazone


The metabolism of Sulfinpyrazone can be decreased when combined with Pioglitazone.

Sulfisoxazole


The metabolism of Pioglitazone can be decreased when combined with Sulfisoxazole.

Sunitinib


Pioglitazone may increase the hypoglycemic activities of Sunitinib.

Tacrolimus


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Tacrolimus.

Tamoxifen


The metabolism of Pioglitazone can be decreased when combined with Tamoxifen.

Tazarotene


The metabolism of Tazarotene can be decreased when combined with Pioglitazone.

Telaprevir


The metabolism of Pioglitazone can be decreased when combined with Telaprevir.

Telithromycin


The metabolism of Pioglitazone can be decreased when combined with Telithromycin.

Temafloxacin


Temafloxacin may increase the hypoglycemic activities of Pioglitazone.

Temazepam


The metabolism of Temazepam can be decreased when combined with Pioglitazone.

Temsirolimus


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Temsirolimus.

Terbinafine


The metabolism of Terbinafine can be decreased when combined with Pioglitazone.

Teriflunomide


The metabolism of Pioglitazone can be decreased when combined with Teriflunomide.

Testosterone


The metabolism of Testosterone can be decreased when combined with Pioglitazone.

Testosterone Cypionate


The metabolism of Testosterone cypionate can be decreased when combined with Pioglitazone.

Testosterone Enanthate


The metabolism of Testosterone enanthate can be decreased when combined with Pioglitazone.

Testosterone Propionate


Testosterone propionate may increase the hypoglycemic activities of Pioglitazone.

Testosterone Undecanoate


The metabolism of Testosterone undecanoate can be decreased when combined with Pioglitazone.

Theophylline


The metabolism of Theophylline can be decreased when combined with Pioglitazone.

Theophylline anhydrous


The metabolism of Theophylline can be decreased when combined with Pioglitazone.

Thioctic Acid


Lipoic Acid may increase the hypoglycemic activities of Pioglitazone.

Thioridazine


The serum concentration of Thioridazine can be increased when it is combined with Pioglitazone.

Ticagrelor


The metabolism of Pioglitazone can be decreased when combined with Ticagrelor.

Ticlopidine


The metabolism of Pioglitazone can be decreased when combined with Ticlopidine.

Tipranavir


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Tipranavir.

Tocilizumab


The serum concentration of Pioglitazone can be decreased when it is combined with Tocilizumab.

Tolazamide


Pioglitazone may increase the hypoglycemic activities of Tolazamide.

Tolbutamide


The metabolism of Pioglitazone can be decreased when combined with Tolbutamide.

Toloxatone


Toloxatone may increase the hypoglycemic activities of Pioglitazone.

Torsemide


The metabolism of Torasemide can be decreased when combined with Pioglitazone.

Tranylcypromine


Tranylcypromine may increase the hypoglycemic activities of Pioglitazone.

Tretinoin


The metabolism of Tretinoin can be decreased when combined with Pioglitazone.

Triamcinolone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Triamcinolone.

Trichlormethiazide


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Trichlormethiazide.

Trimethadione


The metabolism of Trimethadione can be decreased when combined with Pioglitazone.

Trimethoprim


The metabolism of Pioglitazone can be decreased when combined with Trimethoprim.

Triptorelin


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Triptorelin.

Troglitazone


The metabolism of Troglitazone can be decreased when combined with Pioglitazone.

Trolamine Salicylate


Trolamine salicylate may increase the hypoglycemic activities of Pioglitazone.

Trovafloxacin


Trovafloxacin may increase the hypoglycemic activities of Pioglitazone.

Valproate


The metabolism of Pioglitazone can be decreased when combined with Valproic Acid.

Valproic Acid


The metabolism of Pioglitazone can be decreased when combined with Valproic Acid.

Valsartan


The metabolism of Pioglitazone can be decreased when combined with Valsartan.

Velpatasvir


The metabolism of Velpatasvir can be decreased when combined with Pioglitazone.

Vemurafenib


The serum concentration of Pioglitazone can be decreased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Pioglitazone can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Pioglitazone can be decreased when combined with Verapamil.

Voriconazole


The metabolism of Pioglitazone can be decreased when combined with Voriconazole.

Vorinostat


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Vorinostat.

Vortioxetine


The metabolism of Vortioxetine can be decreased when combined with Pioglitazone.

Voxilaprevir


The metabolism of Voxilaprevir can be decreased when combined with Pioglitazone.

Warfarin


The metabolism of Warfarin can be decreased when combined with Pioglitazone.

Zafirlukast


The metabolism of Pioglitazone can be decreased when combined with Zafirlukast.

Zidovudine


The metabolism of Zidovudine can be decreased when combined with Pioglitazone.

Ziprasidone


The metabolism of Pioglitazone can be decreased when combined with Ziprasidone.

Zopiclone


The metabolism of Zopiclone can be decreased when combined with Pioglitazone.

Advertisement
Recommended Reading
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mastering Diabetes: A Comprehensive Guide to Education and Self-Care – An Ebook
Stay Connected
Available on the Android Market Available on the App Store